sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
2-Jul-2016 01:55
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 601-625 out of 1264.

<< < 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 > >>

Public Release: 14-Jul-2015
More women, children now on lifesaving HIV treatment worldwide
Global scale-up of prevention of mother-to-child transmission of HIV services has yielded remarkable results. Between 2000 and 2014, the percentage of pregnant women living with HIV with access to ART rose to 73 percent and new HIV infections among children dropped by 58 percent--leading to 1.4 million averted pediatric HIV infections worldwide.

Contact: Johanna Harvey
jharvey@pedaids.org
202-280-1657
Elizabeth Glaser Pediatric AIDS Foundation

Public Release: 13-Jul-2015
Journal of Bone and Mineral Research
Kidney, bladder stones do not increase postmenopausal women's risk of osteoporosis
Postmenopausal women with kidney or bladder stones are not at increased risk for osteoporosis, but they do have about a 15 percent increased risk of another painful stone, physician-scientists report.

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Augusta University

Public Release: 13-Jul-2015
Journal of Clinical Investigation
Researchers develop aerosolized vaccine that protects primates against Ebola
A collaborative team from the University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
National Institutes of Health

Contact: Donna Ramirez
donna.ramirez@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston

Public Release: 12-Jul-2015
Journal of Experimental Medicine
Scientists find molecular switch that creates long-term immunity
Melbourne researchers have identified a protein responsible for preserving the antibody-producing cells that lead to long-term immunity after infection or vaccination.
Leukaemia Foundation, Australian Research Council, National Health and Medical Research Council, Victorian Government Operational Infrastructure Scheme

Contact: Liz Williams
williams@wehi.edu.au
61-428-034-089
Walter and Eliza Hall Institute

Public Release: 10-Jul-2015
UTHealth's Barbara Murray honored by Rice University
Barbara Murray, M.D., director of the Division of Infectious Diseases at The University of Texas Health Science Center at Houston Medical School, was recognized by the Association of Rice Alumni at its Laureates Dinner May 16.

Contact: Robert Cahill
Robert.Cahill@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston

Public Release: 10-Jul-2015
Plastic and Reconstructive Surgery -- Global Open
Study shows variation in rates of secondary cleft lip and palate surgery
For children with cleft lip and palate, the chances of undergoing secondary surgery vary depending on the center where they're treated, reports a study in Plastic and Reconstructive Surgery -- Global Open®, the official open-access medical journal of the American Society of Plastic Surgeons.

Contact: Connie Hughes
Connie.Hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health

Public Release: 10-Jul-2015
Cell Metabolism
Ancestral diets determine vulnerability to type 2 diabetes
The middle classes from developing countries are more susceptible than western Caucasians to obesity, type 2 diabetes and cardiovascular disease in today's changing environment. New research published today in Cell Metabolism from the University of Sydney in Australia, the National Centre for Cell Science and the DYP Medical College in Pune, India, reveals this may be a result of the nutrition endured by their ancestors.

Contact: Sally Sitou
sally.sitou@sydney.edu.au
61-481-012-597
University of Sydney

Public Release: 9-Jul-2015
Doctors to get better access to digital data
With $1.3 million and a top-priority ranking from the National Institutes of Health, UA College of Engineering researchers are developing data compression software to make biomedical big data universally available.
National Institutes of Health

Contact: Daniel Stolte
stolte@email.arizona.edu
520-626-4402
University of Arizona

Public Release: 9-Jul-2015
Annals of Internal Medicine
Early HIV treatment improves survival in some patients with newly diagnosed TB
Starting anti-HIV treatment within two weeks of the diagnosis of tuberculosis, or TB, improved survival among patients with both infections who had very low immune-cell counts, according to an analysis by researchers at the University of Pittsburgh Graduate School of Health. Those with strong immune systems, however, might benefit from waiting until after the end of the six-month TB treatment before initiating anti-HIV therapy, they found.
Swedish Council for Working Life and Social Research, NIH/National Institute for Allergy and Infectious Disease, AIDS Clinical Trial Group, Stellenbosch University Clinical Trial Unit, Medical Education Partnership Initiative and others

Contact: Allison Hydzik
HydzikAM@upmc.edu
412-647-9975
University of Pittsburgh Schools of the Health Sciences

Public Release: 8-Jul-2015
The Lancet Infectious Diseases
Out-of-pocket health costs tied to antimicrobial resistance, Stanford study finds
The high out-of-pocket costs for antimicrobial drugs in many developing countries is leading to an increase in drug-resistant pathogens, according to a study by Stanford University researchers.
National Institutes of Health

Contact: Beth Duff-Brown
bethduff@stanford.edu
650-736-6064
Stanford University Medical Center

Public Release: 8-Jul-2015
Cell Host & Microbe
Vanderbilt researchers develop antibodies to fight chikungunya virus
Vanderbilt University Medical Center's James Crowe, M.D., Ann Scott Carell Professor and director of the Vanderbilt Vaccine Center, and his team are reporting the first large panel of antibody treatments against the chikungunya virus in the current issue of Cell Host and Microbe.

Contact: Craig Boerner
craig.boerner@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center

Public Release: 7-Jul-2015
BMC Obesity
Higher vitamin D doses may be needed to restore healthy levels in overweight blacks
The current recommended minimum daily dose of vitamin D is not sufficient to restore healthy vitamin D levels in overweight or obese blacks, researchers report.

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Augusta University

Public Release: 7-Jul-2015
Nature Communications
The next anti-tuberculosis drug may already be in your local pharmacy
Testing thousands of approved drugs, EPFL scientists have identified an unlikely anti-tuberculosis drug: the over-the-counter antacid lansoprazole (Prevacid).
Swiss National Science Foundation, German Federal Ministry of Research and Education

Contact: Nik Papageorgiou
n.papageorgiou@epfl.ch
41-216-932-105
Ecole Polytechnique Fédérale de Lausanne

Public Release: 7-Jul-2015
Nature Communications
Study identifies new way to kill the malaria parasite
The discovery could pave the way to new treatments for the disease.
Medical Research Council, Wellcome Trust

Contact: MRC press office
press.office@headoffice.mrc.ac.uk
44-207-395-2345
University of Leicester

Public Release: 6-Jul-2015
Science
Study explains how dengue virus adapts as it travels, increasing chances for outbreaks
A researcher from The University of Texas Medical Branch at Galveston is an integral member of a collaborative group that is the first to explain the mechanisms that the Dengue virus has developed to optimize its ability to cause outbreaks as it travels across the globe to new places and revisits old ones.
The Singapore National Medical Research Council, Ministry of Health in Singapore, Institute of Molecular and Cell Biology, Agency of Science, Technology and Research in Singapore, National Institutes of Health

Contact: Donna Ramirez
donna.ramirez@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston

Public Release: 6-Jul-2015
Hypertension
New blood pressure guidelines may lead to under treatment of older adults
In 2014, the Joint National Committee released the eighth update to the blood pressure guidelines (JNC8P). These guidelines included a controversial decision to change the blood pressure goal that may lead to under treatment of adults 60 years of age or older. The JNC8P guidelines set a less stringent goal blood pressure of < 150/90 mmHg for individuals 60 years of age or older compared to the previous <140/90 mmHg goal.

Contact: Melissa Hanson
mhanson@mhif.org
763-257-2022
Minneapolis Heart Institute Foundation

Public Release: 6-Jul-2015
Safer, with more benefits: Parents' vaccine views shifting
Over the same time period that multiple outbreaks of measles and whooping cough made headlines around the country, parents' views on vaccines became more favorable.

Contact: Beata Mostafavi
bmostafa@umich.edu
734-764-2220
University of Michigan Health System

Public Release: 2-Jul-2015
PLOS Neglected Tropical Diseases
Rope-chewing technique an easy way to screen monkeys for disease
What a piece of rope and strawberry jam have to do with preventing the spread of zoonotic disease.
USAID Emerging Pandemic Threats Program, William J. Fulbright Fellowship

Contact: Tierra Smiley Evans
tsmevans@ucdavis.edu
916-952-0275
University of California - Davis

Public Release: 2-Jul-2015
The Lancet
Millions of children's lives saved through low-cost investments
More than 34 million children's lives have been saved since 2000 because of investments in child health programs at a cost of as little as $4,205 per child, according to a new analysis in The Lancet. From 2000 to 2014, low- and middle-income country governments spent $133 billion on child health. Donors spent $73.6 billion. The governments saved about 20 million children, and the donors saved an additional 14 million children.

Contact: William Heisel
wheisel@uw.edu
206-612-0739
Institute for Health Metrics and Evaluation

Public Release: 2-Jul-2015
Mosquito-borne viruses subject of $4 million in federal grants to Pitt vaccine researchers
Scientists at the University of Pittsburgh Center for Vaccine Research recently received nearly $4 million through five federal grants to study a group of related mosquito-borne viruses. The ultimate goal is to develop vaccines and therapies against the deadly diseases.
National Institutes of Health, US Department of Defense

Contact: Allison Hydzik
hydzikam@upmc.edu
412-647-9975
University of Pittsburgh Schools of the Health Sciences

Public Release: 2-Jul-2015
Cell
Viral protein in their sights
A team from Harvard Medical School, using electron cryomicroscopy, has for the first time revealed at the atomic level the structure of a protein required for viral replication in vesicular stomatitis virus, a virus that is a model for a group of RNA viruses that includes Ebola and other threats to human health.
National Institutes of Health, New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases

Contact: David Cameron
david_cameron@hms.harvard.edu
617-432-0441
Harvard Medical School

Public Release: 2-Jul-2015
Science
Vanderbilt research could lead to vaccines and treatment for dengue virus
Researchers at Vanderbilt University and the National University of Singapore have determined the structure of a human monoclonal antibody which, in an animal model, strongly neutralizes a type of the potentially lethal dengue virus.
National Institutes of Health

Contact: Craig Boerner
craig.boerner@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center

Public Release: 2-Jul-2015
Science
Human antibody blocks dengue virus in mice
Researchers have discovered that a human antibody specific to dengue virus serotype 2, called 2D22, protects mice from a lethal form of the virus -- and they suggest that the site where 2D22 binds to the virus could represent a potential vaccine target.

Contact: Natasha Pinol
scipak@aaas.org
202-326-6440
American Association for the Advancement of Science

Public Release: 1-Jul-2015
Clinical Investigation
Clinical investigation reviews approaches and outcomes of Africa-based HIV trials
A new article in Clinical Investigation highlights the learnings gleaned from monitoring several complex HIV clinical trials in Africa over a 15 year period.

Contact: Leela Ripton
l.ripton@future-science-group.com
44-208-371-6090
Future Science Group

Public Release: 1-Jul-2015
BMC Public Health
Stunting remains a challenge in SA
Stunting remains stubbornly persistent in South Africa, despite economic growth, political and social transitions, and national nutritional programs, says a Wits-led research team. Stunting refers to a reduced growth size in human development and is a chronic form of undernutrition. This issue has several significant public health implications due to increased morbidity and mortality.

Contact: Kemantha Govender
Kemantha.Govender1@wits.ac.za
27-117-171-024
University of the Witwatersrand

Showing releases 601-625 out of 1264.

<< < 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 > >>